CompoAtlas

CURCUMA PLUS

Food supplement declared in France, decision dated 25 April 2026

CURCUMA PLUS (PARAGLYC) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
PARAGLYC
Food business operator placing the product on the market
PARAGLYC
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
4 gélules par jour soit 2400 mg
Directions for use
matin, midi, soir et avant le couché 1 gélule dans un verre d'eau
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans), Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Articulations

Declaration 363389, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Curcuma longa L.RhizomePoudre (de plantes séchées ou broyées)2,113 mg
Piper nigrum L.GrainePoudre (de plantes séchées ou broyées)212 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate de zincZinc25 mg15 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

En cas de prise de médicaments informer votre médecin.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : PARAGLYC